Hyperoxygenated Fatty Acids (HOFAs): The impact of implementation and dissemination on facial pressure injuries from medical devices (HOFA-ID)

Not Applicable

• Conditions: Pressure Injuries; Injuries and Accidents - Other injuries and accidents; Public Health - Other public health

• Registration Number: ACTRN12621001072808
• Lead Sponsor: eanne Hunt

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-08-13
• Last Update Posted: 24 August 2021

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 500

Inclusion Criteria

All adult patients in Intensive Care with facial medical devices (CPAP, BiPAP, ETT, NGT, Nasal prongs, High-flow nasal prongs) as part of their current treatment are eligible to participate in the trial.

Exclusion Criteria

Any patient who does not have a medical facial device implemented as part of their current treatment.
Patients with significant traumatic facial injuries, burns or facial surgery where Hyperoxygenated Fatty Acids are deemed contraindicated.
Patients who at the end-of-life, or are not expected to stay in the ICU for at least 24-hours.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Development of pressure injuries secondary to use of facial medical devices will be determined by visual assessment by nursing staff using the Waterlow assessment<br>[on discharge from ICU and follow up 14 days post discharge.];Pain assessed using the Numeric Pain Rating Scale 1-10.[From time of admission to study to discharge from ICU];Overall length of hospital stay will be assessed by data-linkage to medical records[at discharge from hospital, medical record review.]